Practice Expertise
Areas of Practice
- Competition
- Data & Technology
- Healthcare & Life Sciences
- Intellectual Property
- Public Law & Litigation
- Public Procurement View More
Profile
Tamara Zeiter is an attorney in the Regulated Markets, Competition, Technology and Intellectual Property Team. She advises and represents clients in all areas of administrative law, with a focus on Health and Life Science Law and Competition Law.
Tamara Zeiter studied at the University of Bern (BLaw 2020, MLaw 2022) and at the University of Helsinki (Exchange Semester 2021). During her studies, she worked for a foundation providing seed funding and support to start-ups within different areas of health. Prior to joining Walder Wyss, she worked as a trainee lawyer at Walder Wyss and as a junior law clerk at the Regional Court Oberland in Thun. She was admitted to the bar in 2025.
Tamara Zeiter practices in both German and English. She also speaks French. She is registered with the Zurich Bar Registry and admitted to represent clients in all Swiss Courts.
Tamara Zeiter studied at the University of Bern (BLaw 2020, MLaw 2022) and at the University of Helsinki (Exchange Semester 2021). During her studies, she worked for a foundation providing seed funding and support to start-ups within different areas of health. Prior to joining Walder Wyss, she worked as a trainee lawyer at Walder Wyss and as a junior law clerk at the Regional Court Oberland in Thun. She was admitted to the bar in 2025.
Tamara Zeiter practices in both German and English. She also speaks French. She is registered with the Zurich Bar Registry and admitted to represent clients in all Swiss Courts.
Areas of Practice
- Competition
- Data & Technology
- Healthcare & Life Sciences
- Intellectual Property
- Public Law & Litigation
- Public Procurement
Professional Career
Significant Accomplishments
Genfer Urteil zu Spitalzusatzversicherung (ATAS/939/2025)
Holcim erwirbt CPC AG
Genfer Urteil zu Spitalzusatzversicherung (ATAS/939/2025)
Holcim erwirbt CPC AG
Articles
Kosmetische Behandlungen: schön, gesund oder strafbar?
Zu schön, um wahr zu sein? Die neue EU-Offensive für Medizinprodukte und Diagnostika
Der "Medical Sex and Gender Bias" in der Arzneimittelbranche
Heilmittelsicherheit in der Schweiz: Aus der Perspektive des "Medical Sex and Gender Bias" in der Arzneimittelbranche
Mangelbegriff bei Wohnflächenangaben
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.